Rigel Pharmaceuticals, Inc.RIGLNASDAQ

Revenue (LTM)

$294M

+64.1% YoY

Net Income (LTM)

$367M

+1999.1% YoY

Free Cash Flow

$76M

Revenue CAGR (5Y)

+22.1%

Marginsdeclining

FCF$0.1B

Profitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	149	120↓19.4%	117↓2.8%	179↑53.4%	294↑64.1%
Gross Profit	148	118↓20.0%	110↓7.4%	161↑46.3%	275↑71.0%
Operating Income	-12	-56↓344.5%	-20↑63.1%	24↑218.1%	125↑418.6%
Net Income	-18	-59↓227.0%	-25↑57.2%	17↑169.7%	367↑1999.1%
EBITDA	-11	-54↓377.3%	-17↑68.5%	29↑267.9%	128↑348.5%
EPS Diluted	-1.10	-3.40↓209.1%	-1.44↑57.6%	0.99↑168.7%	19.48↑1867.7%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	19	24↑29.5%	33↑34.0%	57↑73.1%	41↓28.5%
Total Current Assets	154	116↓25.0%	99↓14.4%	135↑36.1%	240↑77.8%
Total Assets	167	134↓19.8%	117↓12.7%	164↑39.9%	514↑213.2%
Total Current Liabilities	64	65↑2.6%	53↓18.3%	63↑18.8%	99↑56.8%
Total Liabilities	137	148↑8.0%	146↓1.4%	161↑10.2%	122↓24.0%
Total Equity	30	-14↓144.8%	-29↓110.4%	3↑111.5%	391↑11806.3%
Total Debt	31	42↑35.9%	61↑45.8%	60↓1.0%	53↓11.1%
Net Debt	12	17↑46.4%	28↑62.6%	3↓88.4%	13↑295.2%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	6	-74↓1354.8%	-6↑92.2%	31↑648.0%	76↑140.4%
Capital Expenditure	-1	-0↑28.2%	-15↓3233.3%	-0↑97.4%	0
Free Cash Flow	5	-74↓1513.2%	-21↑72.0%	31↑249.8%	76↑143.5%
Stock-Based Comp	9	12↑30.6%	9↓28.9%	12↑40.7%	13↑2.6%
Net Change in Cash	-11	6↑148.5%	8↑49.5%	24↑187.7%	-16↓167.2%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance